Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹13.05 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹13.05 Cr |
| Fresh Issue | ₹12.40 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹72.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | ARISTO |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,600 shares and in multiples thereof
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
They deliver their products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.
The industry Aristo Bio-Tech and Lifescience is engaged in, is full of possibilities where the entities deal in the production and distribution of pesticides and fertilizers. All these entities contribute towards enhancing crop yields and their quality.
Aristo Bio-Tech and Lifescience are delivering their products in over 20 states of India. Also, the offerings are extended to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam.
The company is ISO 9001: 2015 certified for their Quality Management System. Following are the products of Aristo:
Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirement | 9.35 |
| 2 | General Corporate Expenses | 2.50 |
| 3 | Public Issue Expenses | 1.20 |
| Period Ended | 30 Sep 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 108.69 | 77.00 | 81.42 | 87.85 |
| Total Income | 129.07 | 166.03 | 167.23 | 201.24 |
| Profit After Tax | 2.59 | 1.46 | 1.08 | 1.01 |
| NET Worth | 17.43 | 14.84 | 13.38 | 12.31 |
| Reserves and Surplus | 12.44 | 9.85 | 8.39 | 7.31 |
| Total Borrowing | 29.36 | 25.48 | 22.25 | 19.71 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 29.26% |
| ROCE | 35.64% |
| Debt / Equity | 5.10% |
| RoNW | 10% |
| PAT Margin | 0.88% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 2.93 | |
| P/E (x) | 9.46 | |
| Promoter Holding | 100.00% | 73.37% |
| Market Cap | ₹49.02 Cr. | |
